Literature DB >> 5237375

Clinical pharmacology of N,N-bis(phenylcarbamolymethyl)dimethylammonium chloride (QX-572), a new antiarrhythmic agent.

M L Schwartz, J Stapleton, B G Covino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5237375     DOI: 10.1002/j.1552-4604.1967.tb00065.x

Source DB:  PubMed          Journal:  J Clin Pharmacol J New Drugs        ISSN: 0095-9863


× No keyword cloud information.
  3 in total

1.  Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.

Authors:  L Rydén; A Hjalmarson; H Wasir; L Werkö
Journal:  Br Heart J       Date:  1974-08

2.  Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man.

Authors:  L Rydén; A Berlin; L R Treiber
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

3.  Effects of the quaternary ammonium compound OX-572 on ventricular tachyarrhythmias complicating acute myocardial infarction.

Authors:  L Rydén; A Hjalmarson; A Waldenström
Journal:  Br Heart J       Date:  1975-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.